UnknownPhase 4

Efficacy and Safety of Topical Insulin for Neurotrophic Corneal Ulcers

14 participantsStarted 2024-04-01

Plain-language summary

To evaluate Safety and efficacy of topical insulin in treatment of neurotrophic corneal ulcers

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with neurotrophic corneal ulcers caused by: * Herpes simplex or Herpes zoster viral infection * Topical anesthetics abuse * Chemical and physical burn * Chronic CL wear * Following LASIK,PRK,CXL * Following vitrectomy and endophotocoagulation for retinal detachment * Diabetes mellitus * Leprosy * Trigeminal neuralgia surgery Exclusion Criteria: * Non compliant patients with the study protocol

What they're measuring

Decrease in ulcer size and the increase in visual acuity .

Timeframe: baseline

Trial details

NCT IDNCT06331910

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-01

View on ClinicalTrials.gov More Neurotrophic Keratopathy trials